ICON is Ireland’s global leader in medical research

ICON plc is a contract research organization (CRO) that provides support services to the medical manufacturing industry.
ICON provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. It is one of a few CROs with the global infrastructure to carry out… Read More

embecta has better rebound potential

These two firms have struggled since being spun off by larger medical firms. While both are taking steps to improve their product lineups, we feel embecta is in a better position to rebound from its recent drop.
VIATRIS INC. $12 is a hold. The company (New York symbol… Read More

Cancer drugs should spur Pfizer

PFIZER INC. $28 is a buy. The drugmaker (New York symbol PFE; Income-Growth Dividend Payer Portfolio, Manufacturing sector; Shares outstanding: 5.6 billion; Market cap: $156.8 billion; Dividend yield: 6.0%; Dividend Sustainability Rating: Highest; www.pfizer.com) raised your annual dividend rate by 2.4% with the March 2024 payment, to $0.42 a.. Read More